Chemistry: molecular biology and microbiology – Vector – per se
Patent
1997-04-08
1999-10-26
Patterson, Jr., Charles L.
Chemistry: molecular biology and microbiology
Vector, per se
435236, 576 231, C07H 1910
Patent
active
059726997
ABSTRACT:
An enzymatic RNA molecule which specifically cleaves a herpes simplex virus mRNA molecule.
REFERENCES:
Taylor and Rossi, "Ribozyme-Mediated Cleavage of an HIV-1 gag RNA: The Effects of Nontargeted Sequences and Secondary Structure on Ribozyme Cleavage Activity," Antisense Res. and Dev. 1:173-186 (1991).
Tsukiyama-Kohara et al., "Internal Ribosome Entry Site Within Hepatits C Virus RNA," Journal of Virology 66:1476-1483 (1992).
Usman et al., "Automated Chemical Synthesis of Long Oligoribonucleotides Using 2'-O-Silylated Ribonucleoside 3'-O-Phosphoramidites on a Controlled-Pore Glass Support: Synthesis of a 43-Nucleotide Sequence Similar to the 3'-Half Molecule of an Escherichia coli Formylmethoionine tRNA," J. Am. Chem. Soc. 109:7845-7854 (1987).
Weerasinghe et al., "Resistance to Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Human CD4.sup.+ Lymphocyte-Derived Cell Lines Conferred by Using Retroviral Vectors Expressing an HIV-1 RNA-Specific Ribozyme," Journal of Virology 65:5531-5534 (1994).
Zuker, "On Finding All Suboptimal Foldings of an RNA Molecule," Science 244:48-52 (1989).
Zuker and Stiegler, "Optimal Computer Folding of Large RNA Sequences Using Thermodynamics and Auxiliary Information," Nucleic Acids Research 9:133-148 (1981).
Haseloff and Gerlach, "Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities," Nature 334:585-591 (1988).
Jaeger et al., "Improved Predictions of Secondary Structures for RNA," Proc. Natl. Acad. Sci. USA 86:7706-7710 (1989).
Kashani-Sabet et al., "Reversal of the Malignant Phenotype by an Anti-ras Ribozyme," Antisense Research & Development 2:3-15 (1992).
Koizumi et al., "Ribozymes Designed to Inhibit Transformation of NIH3T3 Cells by the Activated c=Ha-ras Gene," Gene 117:179-184 (1992).
Mamone et al., "Design of Hammerhead Ribozymes Targeted to Sequences in HIV, HSV and the RAT ANF Gene," Abstract of Keystone, CO (May 27, 1992).
New Riverside University Dictionary , Houghton Miifflin Co., p. 437 (1984).
Pavco et al., "Regulation of Self-Splicing Reactions by Antisense RNA," Abstract of Keystone, CO (May 27, 1992).
Perrotta and Been, "Cleavage of Oligoribonucleotides by a Ribozyme Derived from the Hepatitis .delta. Virus RNA Sequence," Biochemistry 31:16-21 (1992).
Rossi and Sarver, "RNA enzymes (ribozymes) as antiviral therapeutic agents," TIBTECH 8:179-183 (1990).
Sambrook et al., Molecular Cloning: A Laboratory Manual, published by Cold Spring Harbor Laboratory Press, New York, New York, pp. 7.71-7.78 (1989).
Sarver et al., "Ribozymes as Potential Anti-HIV-1 Therapeutic Agents" Science 247:1222-1225 (1990).
Sarver et al., "Catalytic RNAs (Ribozymes): A New Frontier in Biomedical Applications," AIDS Res. Revs. 2:259-285 (1992).
Scanlon et al., "Ribozyme-Mediated Cleavage of c-fos mRNA Reduces Gene Expression of DNA Synthesis Enzymes and Metallothionein," Proc. Natl. Acad. Sci. USA 88:10591-10595 (1991).
Sioud and Drlica, "Prevention of Human Immunodeficiency Virus Type 1 Integrase Expression in Escherichia coli by a Ribozyme," Proc. Natl. Acad. Sci. USA 88:7303-7307 (1991).
Slim and Gait, "Configurationally Defined Phosphorothioate-Containing Oligoribonucleotides in the Study of the Mechanism of Cleavage of Hammerhead Ribozymes," Nucleic Acids Research 19:1183-1188 (1991).
Cameron and Jennings, "Specific Gene Expression by Engineered Ribozymes in Monkey Cells," Proc. Natl. Acad. Sci. USA 86:9139-9143 (1989).
Chen et al., "Multitarget-Ribozyme Directed to Cleave at up to Nine Highly Conserved HIV-1 env RNA Regions Inhibits HIV-1 Replication-Potential Effectiveness Against Most Presently Sequenced HIV-1 Isolates," Nucleic Acids Research 20:4581-4589 (1992).
Chuat and Galibert, "Can Ribozymes be Used to Regulate Procaryote Gene Expression?" Biochemical and Biophysical Research Communications 162:1025-1029 (1989).
Dropulic et al., "Functional Characterization of a U5 Ribozyme: Intracellular Suppression of Human Immunodeficiency Virus Type I Expression," Journal of Virology 66:1432-1441 (1992).
Guerrier-Takada et al., "The RNA Moiety of Ribonuclease P Is the Catalytic Subunit of the Enzyme," Cell 35:849-857 (1983).
Haekh's Chemical Dictionary , 4th edition, edited by J. Grant, McGraw Hill Book Company, p. 242 (1969).
Hampel and Tritz, "RNA Catalytic Properties of the Minimun (-)sTRSV Sequence," Biochemistry 28:4929-4933 (1989).
Hampel et al., "`Hairpin` Catalytic RNA Model: Evidence for Helices and Sequence Requirement for Substrate RNA," Nucleic Acids Research 18:299-304 (1990).
Patterson Jr. Charles L.
Ribozyme Pharmaceuticals Inc.
LandOfFree
Method and reagent for inhibiting herpes simplex virus replicati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and reagent for inhibiting herpes simplex virus replicati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and reagent for inhibiting herpes simplex virus replicati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-762900